MAC13772

CAS No. 4871-40-3

MAC13772 ( MAC 13772 )

Catalog No. M14637 CAS No. 4871-40-3

MAC13772 is a potent inhibitor of BioA with an IC50 of 250 nM, a novel antibacterial inhibitor that selectively inhibits PABA biosynthesis in M tuberculosis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 42 Get Quote
10MG 72 Get Quote
25MG 115 Get Quote
50MG 200 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    MAC13772
  • Note
    Research use only, not for human use.
  • Brief Description
    MAC13772 is a potent inhibitor of BioA with an IC50 of 250 nM, a novel antibacterial inhibitor that selectively inhibits PABA biosynthesis in M tuberculosis.
  • Description
    MAC13772 is a potent inhibitor of BioA with an IC50 of 250 nM, a novel antibacterial inhibitor that selectively inhibits PABA biosynthesis in M tuberculosis.
  • Synonyms
    MAC 13772
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    Antibacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    4871-40-3
  • Formula Weight
    227.24
  • Molecular Formula
    C8H9N3O3S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C1=CC=C(C(=C1)[N+](=O)[O-])SCC(=O)NN
  • Chemical Name
    2-((2-nitrophenyl)thio)acetohydrazide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Zlitni S, et al. Nat Chem Biol. 2013 Dec;9(12):796-804.
molnova catalog
related products
  • MUT-056399

    A novel, highly potent inhibitor of the FabI enzyme of both Staphylococcus aureus and Escherichia coli.

  • Capreomycin sulfate

    A peptide antibiotic, commonly grouped with the aminoglycosides, which is given in combination with other antibiotics for MDR-tuberculosis.

  • N-Acetyl-D-mannosami...

    N-Acetylmannosamine is a drug potentially for the treatment of hereditary inclusion body myopathy.